CRISPR Therapeutics AG Quarterly Return On Assets in % from Q2 2017 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
CRISPR Therapeutics AG quarterly/annual Return On Assets history and growth rate from Q2 2017 to Q3 2024.
  • CRISPR Therapeutics AG Return On Assets for the quarter ending September 30, 2024 was -10.3 %, a 35.9% increase year-over-year.
  • CRISPR Therapeutics AG annual Return On Assets for 2023 was -7.02 %, a 73.9% increase from 2022.
  • CRISPR Therapeutics AG annual Return On Assets for 2022 was -26.9 %, a 286% decline from 2021.
  • CRISPR Therapeutics AG annual Return On Assets for 2021 was 14.5 %.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -10.3 +5.78 +35.9% Jul 1, 2024 Sep 30, 2024
Q2 2024 -11.7 +6.72 +36.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 -9.7 +12.8 +57% Jan 1, 2024 Mar 31, 2024
Q4 2023 -7.02 +19.9 +73.9% Oct 1, 2023 Dec 31, 2023
Q3 2023 -16.1 +10.6 +39.8% Jul 1, 2023 Sep 30, 2023
Q2 2023 -18.4 +5.4 +22.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 -22.5 -33.8 -300% Jan 1, 2023 Mar 31, 2023
Q4 2022 -26.9 -41.4 -286% Oct 1, 2022 Dec 31, 2022
Q3 2022 -26.8 -44.1 -254% Jul 1, 2022 Sep 30, 2022
Q2 2022 -23.8 -45.7 -209% Apr 1, 2022 Jun 30, 2022
Q1 2022 11.3 +36.1 Jan 1, 2022 Mar 31, 2022
Q4 2021 14.5 +40.5 Oct 1, 2021 Dec 31, 2021
Q3 2021 17.3 +35.7 Jul 1, 2021 Sep 30, 2021
Q2 2021 21.9 +19.8 +972% Apr 1, 2021 Jun 30, 2021
Q1 2021 -24.8 -30.4 -549% Jan 1, 2021 Mar 31, 2021
Q4 2020 -26 -35.6 -370% Oct 1, 2020 Dec 31, 2020
Q3 2020 -18.4 -16.3 -796% Jul 1, 2020 Sep 30, 2020
Q2 2020 2.04 +42.1 Apr 1, 2020 Jun 30, 2020
Q1 2020 5.54 +45.4 Jan 1, 2020 Mar 31, 2020
Q4 2019 9.62 +47.7 Oct 1, 2019 Dec 31, 2019
Q3 2019 -2.05 +28.9 +93.4% Jul 1, 2019 Sep 30, 2019
Q2 2019 -40.1 -11.6 -40.7% Apr 1, 2019 Jun 30, 2019
Q1 2019 -39.8 -15.4 -63.3% Jan 1, 2019 Mar 31, 2019
Q4 2018 -38 -14.9 -64.2% Oct 1, 2018 Dec 31, 2018
Q3 2018 -30.9 -14.5 -88.5% Jul 1, 2018 Sep 30, 2018
Q2 2018 -28.5 -15.3 -115% Apr 1, 2018 Jun 30, 2018
Q1 2018 -24.4 Jan 1, 2018 Mar 31, 2018
Q4 2017 -23.2 Oct 1, 2017 Dec 31, 2017
Q3 2017 -16.4 Jul 1, 2017 Sep 30, 2017
Q2 2017 -13.2 Apr 1, 2017 Jun 30, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.